An Open Label Conversion Study of Pramipexole to Ropinirole Controlled Release (CR) in Patients With Parkinson's Disease.
Phase of Trial: Phase III
Latest Information Update: 22 Sep 2015
At a glance
- Drugs Ropinirole (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
- 26 Jun 2008 Status changed fro recruiting to completed.
- 23 Jan 2008 The expected completion date for this trial is now 1 Mar 2008.
- 18 Nov 2006 New trial record.